InnoPharmax Inc. (4172.TWO)

TWD 17.1

(-0.87%)

Total Assets Summary of InnoPharmax Inc.

  • InnoPharmax Inc.'s latest annual total assets in 2023 was 524.19 Million TWD , up 7.13% from previous year.
  • InnoPharmax Inc.'s latest quarterly total assets in 2024 Q2 was 478.06 Million TWD , down 0.0% from previous quarter.
  • InnoPharmax Inc. reported annual total assets of 489.31 Million TWD in 2022, down -12.02% from previous year.
  • InnoPharmax Inc. reported annual total assets of 556.15 Million TWD in 2021, down -18.23% from previous year.
  • InnoPharmax Inc. reported quarterly total assets of 478.06 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • InnoPharmax Inc. reported quarterly total assets of 524.19 Million TWD for 2023 FY, up 7.13% from previous quarter.

Annual Total Assets Chart of InnoPharmax Inc. (2023 - 2019)

Historical Annual Total Assets of InnoPharmax Inc. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 524.19 Million TWD 7.13%
2022 489.31 Million TWD -12.02%
2021 556.15 Million TWD -18.23%
2020 680.17 Million TWD 13.99%
2019 596.71 Million TWD 0.0%

Peer Total Assets Comparison of InnoPharmax Inc.

Name Total Assets Total Assets Difference
Allied Biotech Corporation 2.07 Billion TWD 74.785%
GeneFerm Biotechnology Co., Ltd. 1.17 Billion TWD 55.402%
Easywell Biomedicals, Inc. 1.21 Billion TWD 56.813%
TTY Biopharm Company Limited 9.87 Billion TWD 94.692%
Synmosa Biopharma Corporation 11.72 Billion TWD 95.531%
Orient EuroPharma Co., Ltd. 10.81 Billion TWD 95.152%
Center Laboratories, Inc. 27 Billion TWD 98.059%
Tien Liang BioTech Co., Ltd. 654.03 Million TWD 19.852%
Orient Pharma Co., Ltd. 2.56 Billion TWD 79.545%
Johnson Chemical Pharmaceutical Works Co., Ltd. 1.99 Billion TWD 73.697%
Excelsior Biopharma Inc. 1.57 Billion TWD 66.767%
DV Biomed Co., Ltd. 1.81 Billion TWD 71.081%
Foresee Pharmaceuticals Co., Ltd. 1.86 Billion TWD 71.839%
Handa Pharmaceuticals, Inc. 3.03 Billion TWD 82.741%
UniPharma Co., Ltd. 350.07 Million TWD -49.739%
Anxo Pharmaceutical Co., Ltd. 2.21 Billion TWD 76.372%
Alar Pharmaceuticals Inc. 973.2 Million TWD 46.137%
Winston Medical Supply Co., Ltd. 801.77 Million TWD 34.621%
Mercury Biopharmaceutical Corporation 438.07 Million TWD -19.659%
Bioray Biotech Co., Ltd 542.64 Million TWD 3.4%
TSH Biopharm Corporation Limited 1.39 Billion TWD 62.554%